Joseph E. Bachelder is special counsel at McCarter & English LLP. This post is based on an article by Mr. Bachelder published in the New York Law Journal. Andy Tsang, a senior financial analyst with the firm, assisted in the preparation of the article.
COVID-19 has caused many illnesses and deaths worldwide. It also has caused significant economic loss for many business enterprises and this may impact, in turn, on the compensation those enterprises pay their executives. Today’s column discusses the impact COVID-19 may have on executive compensation.
On March 13, 2020, the President of the United States declared a national emergency beginning as of March 1 based on COVID-19. On March 27, 2020, the President signed into law the Coronavirus Aid Relief and Economic Security Act (the “CARES Act”). COVID-19-related decisions include picking the date to separate pre-COVID-19 and post-COVID-19 periods (the “COVID Start Date”) for compensation or other purposes. For most companies, at the present time, such decisions are at the discretion of the individual company. Exceptions may include companies receiving loans from, or loans guaranteed by, the U.S. Treasury Department. Such loans may be contingent upon agreement by the borrowing company to certain conditions, including the date to be treated as the COVID Start Date.
SEC Should Mandate Disclosures on COVID-19 Risks and Responses
More from: Carter Dougherty, AFR
Carter Dougherty is Communications Director at Americans for Financial Reform. This post is based on a joint letter to the U.S. Securities and Exchange Commission from 98 investors, state treasurers, public interest groups, labor unions, asset managers and securities law experts.
June 16, 2020
The Honorable Jay Clayton Chairman
U.S. Securities and Exchange Commission 100 F Street, NE
Washington, DC 20549
Re: Comprehensive disclosure requirements to allow investors and the public to analyze companies during the COVID-19 pandemic.
Dear Chairman Clayton,
Investors and the general public are struggling to understand how the COVID-19 pandemic is impacting the economy and the financial markets. At the same time, the federal government is distributing trillions of dollars in financial support to mitigate the economic impact of the pandemic. We urge the Securities and Exchange Commission to institute new disclosure requirements to allow investors and the public to analyze how companies are acting to protect workers, prevent the spread of the virus, and responsibly use any federal aid they receive.
Companies who sell their stock to the public must register with the SEC and fulfill periodic disclosure obligations, as defined by the Commission. These disclosures are available to investors and the general public and help contribute to the public understanding of a company’s financial performance and the risks and opportunities that might go along with investing in that company.
READ MORE »